PIMA547965
Ruplizumab Recombinant Human Monoclonal Antibody (hu5c8 (Ruplizumab)), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA547965-Each-of-1 | In Stock | ₹ 46,769.50 |
PIMA547965 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,769.50
GST (18%): ₹ 8,418.51
Total Price: ₹ 55,188.01
Antigen
Ruplizumab
Classification
Recombinant Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 0.02% ProClin 300
Gene Accession No.
P04629
Host Species
Human
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
4914
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Isotype
IgG1 κ
Applications
Flow Cytometry, Inhibition Assays, Western Blot
Clone
hu5c8 (Ruplizumab)
Conjugate
Unconjugated
Gene
Ntrk1
Gene Alias
BG-9588; hu5c8
Immunogen
Human CD40L
Quantity
200 μg
Primary or Secondary
Primary
Target Species
Human
Form
Liquid
Related Products
Description
- Specificity: The antibody binds to CD40L with an IC50 of 0.845 μg/mL
- Ruplizumab is a humanized monoclonal antibody used as an immunosuppressive pharmaceutical and is a component of Antova
- Ruplizumab is an anti-CD40L monoclonal antibody
- The binding of CD40 to its ligand, CD40L is a critical element in T cell activation
- In systemic lupus erythematosus, CD40L is over-expressed on T cells, B cells and monocytes.